Covid-19: FDA removes US authorisation for antibody drug Evusheld. Iacobucci G. BMJ 2023;380:p264.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Iacobucci G. Covid-19: FDA removes US authorisation for antibody drug Evusheld. BMJ 2023;380:p264.
PMID: 36724972